The association between anti-vascular endothelial growth factor (VEGF) drugs and ocular adverse events (AEs) has been reported, but large real-world studies of their association with systemic AEs are

Taylor & Francis Group2024-03-07 更新50

Analysis of potential ischemic effect of intravitreal bevacizumab on unaffected retina in treatment-naïve macular edema due to branch retinal vein occlusion: a prospective, interventional case-series

视网膜静脉阻塞

抗VEGF药物安全性

Background: To study potential ischemic effects of intravitreal Bevacizumab (IVB) on unaffected retina in treatment-naive eyes with macular edema secondary to branch retinal vein occlusion (BRVO) and

NIAID Data Ecosystem40

safetydata_Sangroongruangsri et al2018

抗VEGF药物安全性

视网膜疾病治疗

Dataset for an article entitle "Real world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: a prospective observational study" Published in Clinical Drug

NIAID Data Ecosystem10

safetydata_Sangroongruangsri et al2018

资源简介：

相关数据集